← All agents | ← Research tracker
Regenecyte
PubChem entry
Evidence Summary
Evidence Level: Moderate
Mechanism: Enrollment: Actual, Enrollment: Estimated, Sponsor Type: Industry, Unknown / General
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Related Conditions
Long COVID (no page yet)
Clinical Trials
2 trial(s) registered
NCT07184385: A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition PHASE3 NOT_YET_RECRUITING
NCT05682560: Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome PHASE2 COMPLETED
Key Studies / References